Clinical Assistant Professor, Department of Pediatric and Adolescent Medicine
Biosketch
Carla M Schwalm, MD, is a board-certified pediatric hematologist/oncologist with Bronson Pediatric Hematology/Oncology in Kalamazoo, Michigan. She is a graduate of Indiana University Medical School, Indianapolis, Indiana. She completed a pediatric residency at Eastern Virginia Medical School, Norfolk, Virginia. She then completed a fellowship in pediatric hematology and oncology at the University of Michigan, Ann Arbor, Michigan.
In addition to her clinical duties, Dr. Schwalm serves as Medical Director of Bronson's Pediatric Hematology/Oncology Department, a service deployment leader for Bronson Medical Group, Co-Chair of Bronson's Quality and Safety Committee, and a committee member of several other committees throughout Bronson, including their Central-Line Associated Bloodstream Infection (CLABSI) work group. Her clinical teaching interests relate to all aspects of pediatric hematology and oncology.
-
Board Certification
- American Board of Pediatrics (General Pediatrics)
- American Board of Pediatrics (Pediatric Hematology-Oncology)
-
Education and Training
- Fellowship 2010, Pediatric Hematology and Oncology, Medical School, University of Michigan
- Residency 2007, Pediatrics, Children's Hospital of the King's Daughters, Eastern Virginia Medical School
- MD 2004, School of Medicine, Indiana University
- BS 2000, Chemistry and Biology, University of Indianapolis
-
Research
- Pediatric Hematology & Oncology
- Continuous Quality Improvement
-
Publications
Martin S.D., Davis E.S., Dai C., Boal L.H., Araya B., Brackett J., Dickens D., Kahn A., Martinez I., Sharma A., Schwalm C., Aguayo-Hiraldo P., Bhatia S., Levine J.M., Johnston E.E., Wolfson J.A. Clinical Features and Risk Factors Associated with Multisystem Inflammatory Syndrome in Children with Cancer and COVID-19 JAMA Oncology. 2023;9:1108-1112.
Kahn A.R., Schwalm C.M., Wolfson J.A., Levine J.M., Johnston E.E. COVID-19 in Children with Cancer Current Oncology Reports. 2022;24(3):295-302.
Johnston E.E., Martinez I., Davis E.S., Caudill C., Richman J., Brackett J., Dickens D.S., Kahn A., Schwalm C., Sharma A., Patel P.A., Bhatia S., Levine J.M., Wolfson J.A. SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities Journal of Clinical Oncology. 2021;39(34):3778-3788.
Ludlow A., George N., Glassford M., Udenberg K., Hannibal M.C., Schwalm C., Scott K., Rothstein T.L., Singh S.A. The Use of B-Cell Polysome Profiling to Validate Novel RPL5 (uL18) and RPL26 (uL24) Variants in Diamond-Blackfan Anemia Journal of Pediatric Hematology/Oncology. 2021;43:e336-e340.
Rolland D.C.M., Basrur V., Jeon Y.K., McNeil-Schwalm C., Fermin D., Conlon K., Zhou Y., Ng S., Tsou C.C., Brown N.A., Thomas D.G., Bailey N.G., Omenn G.S., Nesvizhskii A.I., Root D.E., Weinstock D.M., Faryabi R.B., Lim M.S., Elenitoba-Johnson K.S.J. Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas Proceedings of the National Academy of Sciences of the United States of America. 2017;114(25):6581-6586.